Beyond the Snapshot: Navigating the HOPE Era in Hospice

For years, hospice quality reporting was largely a retrospective exercise—a "look-back" at what was documented during admission and discharge via the Hospice Item Set (HIS). However, as of October 1, 2025, the landscape has shifted fundamentally. The Hospice Outcomes and Patient Evaluation (HOPE) tool has officially replaced the HIS, moving the industry from simple documentation checkboxes to a dynamic, real-time assessment of the patient journey. 

For agencies, this isn't just a new form; it is a structural change in how care is delivered, documented, and reimbursed. 

What is the HOPE Assessment? 

The HOPE tool is a standardized assessment designed to capture the clinical, psychosocial, and spiritual needs of a patient at multiple intervals. Unlike the HIS, which only captured data at the start and end of care, HOPE follows the patient through their hospice stay. 

Key Timepoints for Data Collection: 

1. Admission (ADM): Must be completed within 5 days of election. 
2. Update Visit 1 (HUV1): Required between days 6 and 15. 
3. Update Visit 2 (HUV2): Required between days 16 and 30. 
4. Discharge (DC): Completed at the time of discharge. 

Note: The Hospice Update Visits (HUVs) are mandatory for all patients on service during those windows. These visits must be conducted by an RN, as they involve updating the clinical plan of care. 

The "Symptom Impact" Ripple Effect 

One of the most significant changes introduced by HOPE is the focus on Symptom Impact. Clinicians must now rate the severity of eight key symptoms. If a patient’s pain or non-pain symptom is rated as moderate or severe, a Symptom Follow-up Visit (SFV) is triggered. 

• The 2-Day Rule: Agencies must conduct an in-person follow-up visit within two calendar days of the triggering assessment. 

• Operational Strain: This requirement forces agencies to be more agile. A high volume of symptomatic patients could lead to an "onslaught" of required follow-up visits, potentially overwhelming field staff. 

How HOPE Affects Hospice Agencies 

1. Financial Stakes: The 4% Penalty 

Compliance is no longer optional for maintaining a healthy bottom line. CMS has mandated that agencies must submit at least 90% of their required HOPE data or face a 4% annual payment reduction. This penalty makes timely submission to the iQIES system a top priority for administrative teams. 

2. Staffing and Workflow Challenges

The HOPE tool’s impact on the workforce is substantial. It requires: 

• Increased RN Involvement: Since HUVs must be done by an RN, agencies cannot delegate these specific assessments to LPNs/LVNs, even if they are otherwise involved in the care. 
• Mental and Technical Prep: Clinicians are being asked to document from a "patient-lived experience" perspective rather than a task-oriented one. This requires significant "train-the-trainer" investment to ensure documentation meets the new standards. 

3. Technology and Documentation Burden 

Agencies are increasingly looking toward AI-assisted transcription and EMR optimizations to manage the increased documentation load. Because "if it isn't documented, it didn't happen" remains the gold standard for CMS, the more frequent assessment points mean more time behind a screen unless tech solutions are integrated. 

4. Competitive Public Reporting 

Ultimately, the data gathered via HOPE will be used to create outcome-based quality measures. This will allow consumers to compare agencies based on how well they actually manage symptoms, rather than just how fast they complete their initial paperwork. 

Preparing for the Future 

The shift to HOPE represents a move toward Value-Based Care. Agencies that thrive will be those that view HOPE not as a regulatory hurdle, but as a clinical strategy. By leveraging the data from these assessments, directors can identify gaps in care, improve symptom management protocols, and demonstrate the true value of their hospice services. 

Immediate Actions for Directors: 

• Ensure all staff have iQIES accounts and understand the submission timelines. 
• Conduct "mock" HOPE assessments to identify which symptoms most frequently trigger the 2-day follow-up rule. 

• Update your clinical education curriculum to focus on symptom impact documentation. 
• 
  

Are you finding that the 2-day follow-up requirement is putting more pressure on your weekend staffing levels? 

Are your staff struggling?  Do they need expert guidance and education? Call Kenyon HomeCare Consulting at 206-721-5091 or email gkenyon@kenyonhcc.com